Intravenous Versus Subcutaneous Infliximab in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

Post time 2024-4-28 04:58:05

journal：Journal of Crohn's and Colitis

Authors：John David Chetwood; Yvonne Tran; Sreedhar Subramanian; Philip J Smith; Marisa Iborra; Anthony Buisson; Sudarshan Paramsothy; Rupert W Leong;

Published date：--

DOI：10.1093/ecco-jcc/jjae059

PDF link：https://academic.oup.com/ecco-jc ... 7321682/jjae059.pdf

Article link：http://dx.doi.org/10.1093/ecco-jcc/jjae059

Article Source：Oxford University Press (OUP)。

Remark：

Post time 2024-4-28 04:58:06

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Oxford] Intravenous Versus Subcutaneous Infliximab in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Oxford] Intravenous Versus Subcutaneous Infliximab in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis Copy